Dehydronandrolone Acetate, with the CAS number 2590-41-2, is a synthetic anabolic steroid derived from nandrolone. It is characterized by its modification of the nandrolone structure, specifically the reduction of the double bond at the 4-position, which enhances its anabolic properties while reducing androgenic effects. This compound is typically used in veterinary medicine and has been studied for its potential applications in muscle wasting conditions. Dehydronandrolone Acetate is known for its ability to promote protein synthesis and muscle growth, making it of interest in both medical and athletic contexts. It is administered via injection, as it is not effective when taken orally due to its rapid metabolism. Like other anabolic steroids, it may have side effects, including hormonal imbalances and cardiovascular issues, particularly with prolonged use. Its legal status varies by country, often classified under controlled substances due to its potential for abuse in sports and bodybuilding.

Dehydronandrolone Acetate

2590-41-2: 17b-Acetyloxy-estra-4,6-diene-3-one, 17β-Acetoxy-4,6-estradien-3-one, Dehydronandrolon

6-Dehydronandrolone Acetate

Dehydronandrolon

6-Dehydro Nandrolone Acetate

Dehydronandrolon is an alkene that has been shown to have a matrix effect in women. It has been shown to be effective for the treatment of menopausal symptoms and postoperative pain. Dehydronandrolon is metabolized by CYP3A4 and can inhibit estrogen production. This drug also binds to trenbolone and estrogens, which may account for its anti-cancer effects.

CAS 2590-41-2: Dehydronandrolone Acetate

6-Dehydronandrolone Acetate

Ref: 3B-D5471

Dehydronandrolon

Ref: ST-EA-CP-N54013

6-Dehydro Nandrolone Acetate

Ref: TR-D229125

Dehydronandrolon

Ref: 3D-FD158890